Unknown

Dataset Information

0

Surgical treatment of locally advanced thyroid cancer.

ABSTRACT: Operations in this area are demanding and require special experience in endocrine, thoracic and vascular surgery, an experienced anaesthesiologist, as well as the interdisciplinary cooperation with other medical specialists (nuclear medicine, oncology, radiology, otolaryngology). A reliable system of surgical guidelines has been developed from a few individual publications with special impact.

SUBMITTER: Roka R 

PROVIDER: S-EPMC7798306 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Current status of non-surgical treatment of locally advanced pancreatic cancer.
| S-EPMC8713317 | biostudies-literature
Unknown Challenges and shifting treatment strategies in the surgical treatment of locally advanced rectal cancer.
| S-EPMC7382439 | biostudies-literature
Unknown Oncologic and functional outcomes following laryngectomy for locally advanced thyroid cancer.
| S-EPMC7770003 | biostudies-literature
Unknown Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.
| S-EPMC5791845 | biostudies-literature
Unknown Surgical treatment of advanced penile cancer.
| S-EPMC5565651 | biostudies-literature
Unknown Novelties in treatment of locally advanced rectal cancer.
| S-EPMC6281002 | biostudies-literature
Unknown Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection.
| S-EPMC6985003 | biostudies-literature
Unknown Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer.
| S-EPMC6556697 | biostudies-literature
Unknown Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment.
| S-EPMC8319733 | biostudies-literature
Unknown Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer.
| S-EPMC2902067 | biostudies-literature